CPIX (Cumberland Pharmaceuticals) Short-Term Debt to Capital

Corporate company logo of Cumberland Pharmaceuticals (CPIX)

This price chart helps assess the strategy of Cumberland Pharmaceuticals (CPIX), which relies on B2B sales of antibiotics and analgesics to hospitals. The impeccable reputation of Cumberland Pharmaceuticals among physicians guarantees market loyalty, with the indicator standing at 0.04. However, trade conflicts pose threats to production due to raw material shortages and disruptions in global component supplies.

Ratio of Short-Term Indebtedness to Capital: Cumberland Pharma (CPIX) for 07/04/2022 - 10/31/2026

Analytical breakdowns for Cumberland Pharmaceuticals

- stock quotes and analyst forecast:
Stock Price Cumberland Pharma|CPIX - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Cumberland Pharmaceuticals Inc|CPIX - Enterprise Value
- book capitalization information:
Net Assets per Single Share Cumberland Pharmaceuticals|CPIX - Accounting Value of Company|Market Value to Book Value Ratio cumberlandpharma.com|CPIX - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Cumberland Pharmaceuticals|CPIX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Cumberland Pharmaceuticals Inc.|CPIX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Cumberland Pharmaceuticals Inc|CPIX - Long-Term Debt|Company Current Liabilities Cumberland Pharmaceuticals|Quick Ratio cumberlandpharma.com
- company profitability and valuation multiples indicators:
CPIX - Final Profit
Fundamental valuation:CPIX Cumberland Pharma
Brand item of Cumberland Pharmaceuticals Inc

This indicator determines the company's dependence on obligations with a maturity of up to one year relative to its own equity, revealing hidden liquidity risks. By analyzing the current short-term debt-to-equity ratio on GURU.Markets, an investor assesses the financial stability of Cumberland Pharmaceuticals (CPIX), which is critical for maintaining its status as a reliable supplier of vital medications to the US hospital network.

Competitors of Cumberland Pharmaceuticals (CPIX)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital BHST (BioHarvest Sciences Inc.)|EXOZ - Short-Term Debt to Equity Ratio|ORMP: Short-Term Debt to Equity Ratio|ENTX - Short-Term Debt to Capital|MindWalk Holdings (HYFT) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio abvcpharma.com|QNTM (Quantum BioPharma) - Short-Term Debt to Capital|Short-Term Debt to Equity FGEN|Short-Term Debt to Capital TELO|RANI - Current Liabilities to Capital|Short-Term Debt to Equity Synergy CHC SNYR|Ratio of Short-Term Indebtedness to Capital RLYB|LEXX - Short-Term Debt to Equity|PULM: Short-Term Debt to Equity|PTHL: Short-Term Debt to Capital|Aptorum Group (APM) - Short-Term Debt to Capital|Short-Term Debt to Equity Lyra Therapeutics, Inc.|Short-Term Debt to Capital Ratio IBO (impactbiomedinc.com)|Short-Term Debt to Capital TNFA|cbdmd.com - Short-Term Debt to Capital Ratio|PainReform Limited - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CYTO|LIPO - Short-Term Debt to Equity|Current Liabilities to Equity OPTN|PIRS: Short-Term Debt to Capital|Procaps Group - Ratio of Short-Term Indebtedness to Capital|PTPI (Petros) - Short-Term Debt to Capital|Short-Term Debt to Capital Qilian International Corp|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|TFFP (tffpharma.com) - Ratio of Short-Term Indebtedness to Capital